Research initiated at the Feinstein Institute for Medical Research has demonstrated that electrical stimulation of neural pathways to the spleen effectively prepares the body for clotting. When brought to market, the neural tourniquet
will help reduce blood loss by as much 50 percent, in both time and volume, by helping the blood clot more rapidly. This is one of many new and exciting developments, providing ample opportunities for commercialization. The neural tourniquet has the potential to impact millions of lives per year. There are over 50 million inpatient surgeries conducted annually in the United States. Being able to proactively control blood loss
during these procedures can decrease the need for blood transfusions, alleviate risks of post-surgical complications, and positively impact the patient’s recovery. Similarly, emergency workers responding to accident scenes and traumas may someday benefit from the fast acting nature of the technology.